Phase 2 Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been officially diagnosed with Parkinson's disease (with no other known cause for it)
- You are able to take the study medication yourself, or you have a caregiver who can help you take it throughout the study
- You are willing to keep your diet, exercise routine, and current medications the same as when you started the trial (necessary changes are allowed)
- If you take any Parkinson's medications or supplements, you have been on the same dose for at least 30 days before your first screening visit
- If you take medication for depression or anxiety, you have been on the same dose for at least 90 days before your screening visit
Who may not be able to join:
- You have been diagnosed with Type 1 or Type 2 Diabetes
- Your HbA1c blood sugar level is 6.5% or higher (a measure of long-term blood sugar — confirm with trial site)
- You have a history of episodes of dangerously low blood sugar with symptoms
- Your score on a standard memory and thinking test (called the MMSE) is 24 or below at your screening visit
- You tested positive for COVID-19 at your screening visit or within the 30 days before it
- A medication that could affect your thinking or memory had its dose changed or increased in the 8 weeks before screening or during the study
- You have ongoing nasal problems such as chronic nasal inflammation, frequent nosebleeds, uncontrolled hay fever, or a dust mite allergy that could stop the study medication from being absorbed properly
- You have poorly controlled breathing conditions such as asthma or chronic obstructive pulmonary disease (COPD)
- You have a history of any significant neurological or mental health condition other than Parkinson's disease
- You have epilepsy, have had a seizure as an adult within the past year, have had an unexplained loss of consciousness recently, or have had a serious head injury that caused loss of consciousness
- You have had a stroke (certain types) that left you with lasting neurological effects (confirm with trial site)
- You have heart disease that is unstable or not well controlled and could put you at additional risk
- You currently use insulin or other blood sugar-lowering medications (except if only used during pregnancy-related diabetes), or you take glutathione (GSH) supplements or any supplement known to raise glutathione levels in the body
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 786-216-5334
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Verbal Fluency
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.